Chao Feng Hao

Director of Finance/CFO bei Jiangsu Cowin Biotech Co., Ltd.

Vermögen: 24 739 $ am 31.03.2024

42 Jahre

20 Beziehungen

Health Technology

Consumer Services

Producer Manufacturing

Profil

Chao Feng Hao is currently the Finance Director & Deputy General Manager at Jiangsu Cowin Biotech Co., Ltd.
Prior to this, he worked as the Chief Financial Officer at Shanghai Shyndec Pharmaceutical Co., Ltd.
and WPG (Shanghai) Smart Water Public Co., Ltd.
Mr. Hao completed his undergraduate degree at Zhengzhou Institute of Aeronautical Industry Management.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. CLASS A 0,00%	14.04.2023	20 000 ( 0,00% )	24 739 $	31.03.2024

Aktive Positionen von Chao Feng Hao

Unternehmen	Position	Beginn
Jiangsu Cowin Biotech Co., Ltd. Jiangsu Cowin Biotech Co., Ltd. BiotechnologyHealth Technology Jiangsu Cowin Biotech Co., Ltd. engages in the provision of molecular testing services as well as the research and development of molecular testing products. Its products include raw materials for molecular detection enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents, and molecular diagnostic kits. The company was founded by Chun Xiang Wang on September 3, 2010 and is headquartered in Taizhou, China.	Director of Finance/CFO	27.10.2023